NCT02714387 Non Traumatic Neuro-Vascular Diseases Critical Complications : a Prospective Cohort Study
| NCT ID | NCT02714387 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nantes University Hospital |
| Condition | Non Traumatic Acute Brain Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2013-02 |
| Primary Completion | 2050-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2013-02 with a primary completion date of 2050-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this observational epidemiological study is to investigate the management and the complications associated with Non Traumatic Neuro-Vascular Diseases. Data will be analysed to answer pre-defined scientific projects and to improve management of these conditions.
Eligibility Criteria
Inclusion Criteria: * Non Traumatic Neuro-Vascular Diseases Exclusion Criteria: * Consent withdrawal
Contact & Investigator
Karim Asehnoune, PhD, MD
STUDY CHAIR
Frequently Asked Questions
Who can join the NCT02714387 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, studying Non Traumatic Acute Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02714387 currently recruiting?
Yes, NCT02714387 is actively recruiting participants. Contact the research team at karim.asehnoune@chu-nantes.fr for enrollment information.
Where is the NCT02714387 trial being conducted?
This trial is being conducted at Angers, France, Brest, France, Nantes, France, Poitiers, France and 2 additional locations.
Who is sponsoring the NCT02714387 clinical trial?
NCT02714387 is sponsored by Nantes University Hospital. The principal investigator is Karim Asehnoune, PhD, MD. The trial plans to enroll 5,000 participants.